Liver Cancer News and Research

RSS
Liver cancer is more common in older people. Over half of people newly diagnosed with liver cancer are age 65 and over. Liver cancer is more common in men than in women. Liver cancer rates are highest among Asians and Pacific Islanders, most likely because of higher prevalence of viral Hepatitis infection. Liver cancer rates are lower among whites than Blacks or Asians and Pacific Islanders. At this time, we do not know exactly what causes cancer of the liver. There are several different types of liver cancer. The most common type is associated with long-term excessive alcoholic beverage use, scarring of the liver (cirrhosis), and Hepatitis B virus or Hepatitis C virus infection. Long-term use of anabolic steroids can also increase the risk of getting liver cancer. Smoking is also believed to increase the risk of getting liver cancer.
Study sheds new light on body's immune response to hepatitis A, C viruses

Study sheds new light on body's immune response to hepatitis A, C viruses

Australians getting fatter but living longer and smoking less: Health report card

Australians getting fatter but living longer and smoking less: Health report card

Theorem Clinical Research receives contract to conduct Nordion's TheraSphere Phase III trials

Theorem Clinical Research receives contract to conduct Nordion's TheraSphere Phase III trials

Alios, Vertex sign worldwide license agreement to develop new hepatitis C combination medicines

Alios, Vertex sign worldwide license agreement to develop new hepatitis C combination medicines

HHS adds eight substances to 12th Report on Carcinogens

HHS adds eight substances to 12th Report on Carcinogens

Eliminating ABCB5-expressing cells crucial for successful colorectal cancer treatment

Eliminating ABCB5-expressing cells crucial for successful colorectal cancer treatment

Rockefeller, Scripps Research develop first genetically humanized mouse model for hepatitis C

Rockefeller, Scripps Research develop first genetically humanized mouse model for hepatitis C

Hepatitis C patients with chronic liver disease may benefit from drinking coffee during treatment

Hepatitis C patients with chronic liver disease may benefit from drinking coffee during treatment

Denali, Can-Fite sign agreement to conclude ophthalmology spinoff

Denali, Can-Fite sign agreement to conclude ophthalmology spinoff

Alnylam's ALN-VSP Phase I trial data on liver cancer presented at ASCO 2011

Alnylam's ALN-VSP Phase I trial data on liver cancer presented at ASCO 2011

Newly diagnosed cancer patients face hurdles in receiving oncologist's appointment

Newly diagnosed cancer patients face hurdles in receiving oncologist's appointment

Noninvasive diagnostics may offer alternative to liver biopsy for assessing liver fibrosis

Noninvasive diagnostics may offer alternative to liver biopsy for assessing liver fibrosis

Novel hepatitis C-like virus discovered in dogs

Novel hepatitis C-like virus discovered in dogs

Vertex Incivek receives FDA approval for treatment of chronic hepatitis C

Vertex Incivek receives FDA approval for treatment of chronic hepatitis C

Vertex receives FDA approval for INCIVEK to treat hepatitis C

Vertex receives FDA approval for INCIVEK to treat hepatitis C

Jennerex presents positive preliminary data from JX-594 Phase 2 trial for advanced liver cancer

Jennerex presents positive preliminary data from JX-594 Phase 2 trial for advanced liver cancer

Bayer, Onyx to present Nexavar-chemotherapy combination Phase 2b trial data in breast cancer at ASCO 2011

Bayer, Onyx to present Nexavar-chemotherapy combination Phase 2b trial data in breast cancer at ASCO 2011

Positive results from Onyx's carfilzomib Phase 2b 003-A1 study in relapsed and refractory multiple myeloma

Positive results from Onyx's carfilzomib Phase 2b 003-A1 study in relapsed and refractory multiple myeloma

Abbott RealTime PCR assay for measuring HCV viral load receives FDA marketing approval

Abbott RealTime PCR assay for measuring HCV viral load receives FDA marketing approval

Over-activation of single gene promotes leukemia, but its loss causes liver cancer

Over-activation of single gene promotes leukemia, but its loss causes liver cancer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.